Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Boonacker CWB, Rovers MM, Browning GG, et al. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis. Southampton (UK): NIHR Journals Library; 2014 Jan. (Health Technology Assessment, No. 18.5.)
Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis.
Show detailsn (%) | Adenoidectomy without grommets (n = 95)a | Non-surgical (n = 343)b | RD (95% CI)c | NNTc | RR or mean difference (95% CI)c | Adjusted RR or mean difference (95% CI)c | p-value for interactionc | |
---|---|---|---|---|---|---|---|---|
Primary outcome: failure after 12 months, n/N (%) | ||||||||
Indication recurrent AOM | 281 (64.2) | 20/60 (33.3) | 84/221 (38.0) | −4.7% (−18.2% to 8.9%) | 22 | 0.88 (0.59 to 1.30) | 0.75 (0.49 to 1.12) | |
Indication persistent OME | 157 (35.8) | 7/35 (20.0) | 109/122 (89.3) | −69.3% (−83.7% to −55.0%) | 2 | 0.22 (0.12 to 0.44) | 0.22 (0.12 to 0.44) | < 0.01 |
< 2 years | 280 (63.9) | 20/60 (33.3) | 84/220 (38.2) | −4.9% (−18.4% to 8.7%) | 21 | 0.87 (0.59 to 1.30) | 0.74 (0.49 to 1.11) | |
≥ 2 years | 158 (36.1) | 7/35 (20.0) | 109/123 (88.6) | −68.8% (−83.0% to −54.2%) | 2 | 0.23 (0.12 to 0.44) | 0.22 (0.12 to 0.44) | < 0.01 |
Secondary outcome: presence of effusion for ≥ 50% of the time, n/N (%) | ||||||||
Indication recurrent AOM | 201 (58.8) | 0/60 (0.0) | 0/141 (0.0) | NA | – | – | – | |
Indication persistent OME | 141 (41.2) | 0/29 (0.0) | 83/112 (74.1) | −74.1% (−82.2% to −66.0%) | 2 | – | – | < 0.01 |
< 2 years | 200 (58.5) | 0/60 (0.0) | 0/140 (0.0) | NA | – | – | – | |
≥ 2 years | 142 (41.5) | 0/29 (0.0) | 83/113 (73.5) | −73.5% (−81.6% to −65.3%) | 2 | – | – | < 0.01 |
Secondary outcome: time with effusion during the first 12 months of follow-up (weeks), mean (SD) | ||||||||
Indication recurrent AOM | 201 (58.8) | 1.1 (3.5) | 1.3 (3.0) | – | – | −0.2 (−1.1 to 0.8) | −0.4 (−1.4 to 0.6) | |
Indication persistent OME | 141 (41.2) | 3.8 (2.6) | 36.8 (15.1) | – | – | −33.0 (−38.6 to −27.5) | −33.0 (−35.9 to −30.1) | < 0.01 |
< 2 years | 200 (58.5) | 1.1 (3.5) | 1.3 (3.0) | – | – | −0.2 (−0.9 to 0.4) | −0.4 (−1.4 to 0.6) | |
≥ 2 years | 142 (41.5) | 3.8 (2.7) | 36.5 (15.3) | – | – | −32.7 (−35.7 to −29.7) | −33.0 (−35.9 to −30.1) | < 0.01 |
- Significant interaction effects for adenoidectomy without grommets compared with...Significant interaction effects for adenoidectomy without grommets compared with non-surgical treatment - Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis
- Decision curves for prediction models of early-onset pre-eclampsia in (a) SCOPE ...Decision curves for prediction models of early-onset pre-eclampsia in (a) SCOPE UK, (b) Poston et al. 2015 and (c) POP - Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
- Comparison of clinical characteristic and biochemical marker models in data impu...Comparison of clinical characteristic and biochemical marker models in data imputed with original biochemical markers or natural log-transformed biochemical markers - Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
- Number and percentage of children failing according to each component of the com...Number and percentage of children failing according to each component of the composite end point - Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis
- End of trial for pump participants: standard operating procedure - A cluster ran...End of trial for pump participants: standard operating procedure - A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
Your browsing activity is empty.
Activity recording is turned off.
See more...